The ongoing COVID-19 pandemic — and the worldwide reaction to it — has compelled companies to radically rethink their strategies and the way they operate. We salute the industry experts helping companies survive and sustain in this pandemic.
At MarketsandMarkets™, analysts are undertaking continuous efforts to provide analysis of the COVID-19 impact on the Embolotherapy Market. We are working diligently to help companies take rapid decisions by studying:
- The impact of COVID-19 on the Embolotherapy Market, including growth/decline in product type/use cases due to the cascaded impact of COVID-19 on the extended ecosystem of the market
- The rapid shifts in the strategies of the Top 50 companies in the Embolotherapy Market
- The shifting short-term priorities of the top 50 companies’ clients and their client’s clients
You can request an in-depth analysis detailing the impact of COVID-19 on the Embolotherapy Market:
Let’s fight this crisis together. Speak to Our Analyst to analyse how COVID-19 to analyse how it is impacting your clients and your client’s clients. @ https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=185897830
According to the new market research report “Embolotherapy Market by Product (Embolic Agents (Microspheres, Detachable Coils, Pushable Coils), Guidewires), Disease (Oncology, Aneurysm, Peripheral Vascular), Procedure, End User (Hospitals, Clinics, ASC, Academia) — Global Forecast to 2024“, published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities in North America, Europe, Asia-Pacific, and the Rest of the world (RoW).
Embolotherapy Market is projected to reach USD 4.9 billion by 2024 from USD 3.3 billion in 2019, at a CAGR of 8.1% from 2019 to 2024.
The growth of the Embolotherapy Market is mainly attributed to factors such as the growth in the target patient population, rising preference for minimally invasive procedures, technological advancements in embolotherapy devices, and favorable reimbursement scenario.
The embolic agents segment accounted for the largest share of the Embolotherapy Market, by product, in 2019
Based on product, the Embolotherapy Market is segmented into embolic agents (embolic coils, embolic plug systems, liquid embolic agents, microspheres, and detachable balloons) and support devices (microcatheters and guidewires). Microspheres accounted for the largest share of the Embolotherapy Market in 2018. Market growth in this segment is attributed to the surge in the prevalence of hepatocellular carcinoma (microspheres are widely used to treat this disease), coupled with favorable reimbursement criteria in developed economies.
Browse in-depth TOC on “Embolotherapy Market”
184 — Tables
37 — Figures
219 — Pages
Request Sample Pages — https://www.marketsandmarkets.com/requestsampleNew.asp?id=185897830
The cancer segment is projected to hold the largest share of the market by disease indication during the forecast period of 2019 to 2024
By disease indication, the Embolotherapy Market is classified into cancer, peripheral vascular diseases, neurological diseases, urological & nephrological disorders, and gastrointestinal disorders. The cancer segment held the largest share of the Embolotherapy Market in 2019. The rising preference for minimally invasive procedures, expansion of the target patient population, growing public-private funding & government support for cancer research, and technological advancements in the field of microspheres are driving the growth of this segment.
Hospitals and clinics were the key end users in the Embolotherapy Market
On the basis of end users, the Embolotherapy Market is segmented into hospitals and clinics, ambulatory surgery centers (ASCs), and other end users. In 2018, the hospital and clinics segment held the largest share of the Embolotherapy Market. The growing adoption of minimally invasive surgical procedures (including vascular, urological, and neurological procedures), increasing purchasing power of major healthcare providers across developed countries (owing to the consolidation of healthcare providers), and the greater availability of reimbursements for target procedures in the US and major European countries are the major factors that are expected to drive the demand for embolization devices in hospitals and clinics.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=185897830
North America is expected to accounted for the largest share of the Embolotherapy Market in 2019
The Embolotherapy Market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is projected to hold the largest share of the regional market for embolotherapy products in 2019. The growing geriatric population, the increasing number of ASCs, and a growing preference for minimally invasive surgeries have resulted in the increasing adoption of embolotherapy procedures in the country.
Leading Companies
The major players in the market include Boston Scientific Corporation (US), Merit Medical Systems (US), Terumo Corporation (Japan), Medtronic plc (Ireland), Johnson & Johnson (US), Stryker Corporation (US), BTG plc (UK), Penumbra, Inc. (US), Cook Medical (US), Abbott Laboratories (US), Acandis GmbH (Germany), BALT Extrusion (France), Sirtex Medical Limited (Australia), Kaneka Corporation (Japan), and Meril Life Sciences Pvt. Ltd. (India) among others.
Increasing incidences of peripheral vascular diseases, liver cancer, strokes, and uterine fibroids coupled with rising preference for minimally invasive procedures; increasing investments, funds, and grants by public-private organizations for research; and technological advancements in the market will fuel the market growthGrowth in Embolotherapy MarketThe embolotherapy market is projected to reach $4.9 billion by 2024 from $3.3 billion in 2019, at a CAGRof 8.1% from 2019 to 2024.
The growth of the embolotherapy market is mainly attributed to factors such as the growth in the target patient population, rising preference for minimally invasive procedures, technological advancements in embolotherapy devices, and favorable reimbursement scenario.Product of Embolotherapy MarketMarket is broadly segmented into embolic agents and support devices.
The embolic agents segment is further subsegmented into embolic coils, embolic plug systems, liquid embolic agents, microspheres, and detachable balloons.
The microspheres segment under embolic agents held the largest share of the market in 2018.
The market growth of this segment is majorly driven by the surge in the prevalence of hepatocellular carcinoma (microspheres are widely used to treat this disease), coupled with favorable reimbursement criteria in developed economies.
Moreover, new product launches and approvals are further supporting the growth of this segment.Download PDF Brochure – https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=185897830Diseases In terms of disease indication, embolotherapy market is classified into cancer, peripheral vascular diseases, neurological diseases, urological & nephrological disorders, and gastrointestinal disorders.
Aneurysm Coiling & Embolization Devices Market is expected to grow at a significant CAGR in the upcoming years as the scope, product types and its applications are increasing across the globe.
In Aneurysm Coiling & Embolization Devices, the endovascular coiling separates an aneurysm from getting entangled with the usual movement without blocking any small arteries close to the main vessel.
The endovascular coiling proves to be a slightly offensive technique of opening the aneurysm from within the bloodstream, particularly during angiography.Request a Sample Copy of This Report @ https://www.millioninsights.com/industry-reports/aneurysm-coiling-embolization-devices-market/request-sampleThe Aneurysm Coiling & Embolization Devices are the ones in which the Embolization Device (PED) is specified for the endovascular action of adults (22 years of age or grown-ups) with giant wide-necked intracranial aneurysms (lAs) in the inner carotid vein from the petrous to the larger hypophyseal sections.
Aneurysm Coiling & Embolization Devices Market is categorized based on product type, applications, and geography.
Aneurysm Coiling & Embolization Devices Market is categorized based on product types such as Flow Diversion Devices, Embolic Coils, Liquid Embolic Agents.
Aneurysm Coiling & Embolization Devices Market is categorized based on application into Hospitals, Ambulatory Surgical Units, and Clinics.Aneurysm Coiling Coiling & Embolization Devices Market Embolization Devices Market is categorized based on geography into Asia Pacific (China, India, ASEAN, Australia & New Zealand), Japan, Middle East and Africa (GCC countries, S. Africa, Rest of MEA), North America (U.S., Canada), Latin America (Brazil, Rest of Latin America), Western Europe (Germany, Italy, France, England, Spain, Rest of Western Europe), and Eastern Europe (Poland, Russia, Rest of Eastern Europe).Browse Full TOC of This Report @ https://www.millioninsights.com/industry-reports/aneurysm-coiling-embolization-devices-market
